The Journal of Bone and Joint Surgery, Inc.

Yeah.

And we, we've, we've interviewed people like Tom Einhorn, uh, who was our editor for JBJS Reviews for more than a decade, and his interest in music and others like you that have had, uh...

You, you've been able to bring, bring it back around, if you will, after you're a little farther along in your career-

Mm-hmm

Welcome to JBJS OrthoCore.

Listen as members of the ortho community, residents, surgeons, educators, staff, and patients share their stories about the experiences and people most important in their lives and the lessons they learned along the way.

OrthoCore is an audio archive inspired by StoryCorps and independently organized by the Journal of Bone and Joint Surgery.

Welcome to Your Case is on Hold, the JBJS podcast hosted by Andrew Schoenfeld and Aisha Adbeam.

Here we discuss the best of what each issue of JBJS has to offer with the usual dose of entertainment and pop culture.

Take us with you in the gym, on the commute, and as ever, whenever your case is on hold.

back to another episode of Your Case is on Hold, episode number 114.

Wow.

And that came to mind with this work as well as I was reading it.

So the premise here that I was not familiar with the CIFSO trial, and that is because it was published in the eClinical Medicine Journal in 2024, which seems unusual to me that it would publish there and then this concise follow-up publishes in JBJS, but...

Interesting.

You just can't say these patients need cement.

It's the stem, not the cement, and, and we published on that in JBJS, um, and showed that actually there's a huge spread of performance for cement-less and cemented, and it really depends what your stem is.

So my, my first issue is with the sort of broad use of cement and, and hopefully that will change because there are some quite stark differences between the two.

Um, I think, I, I think as well with the addition of RF, which accounts for, you know, 30% of failures, um, in most stems, but in cemented stems, it accounts for 60% of failures which are not being recorded-

Not again, not just doing the surgeries, but doing stuff as we were talking before you recorded outside of orthopedics and educating people, because I think.

People are consuming content, not reading JBJS or Journal of Arthroplasty or reading Hoppenfeld's anymore.

Like when you were a PGY2, they're getting it more and more online.

So I don't know my story about orthopedics.

It's important work.

You did touch on the paper that you published, the prospective randomized trial in, I think, JBJS, comparing the one-stage and two-stage exchange for periprosthetic joint infection.

So for patients who might not know the gold standard, it's always this two-stage exchange where you would go in, remove an infected implant, and you'd put a spacer of some sort with antibiotics loaded into the implant.

And then you just plan to come back for a second stage where you remove that spacer and put in a more permanent joint replacement.

So publication fees are expensive, and not a lot of people have the opportunity or funding to do so.

So our members, if they submit to JBJS or JPOS's n- next issue next month, we will give you the money to, to have that, uh, publication.

And so we're, we're sort of past just the actual, like, let's support each other and talk to each other, to how do we financially support you in these development opportunities? How do we get you the grand rounds and the visibility and making those network? And that's been a whole shift under my pillars of my presidency, is we have to go leave the talking to each other and the support and what we're struggling with to actionable ways to actually get elevated in orthopedics.

In addition to all that, over the past couple years, I think we've seen a more formalization of our education committee.

[laughs]

... you know, and just, just, uh, e- every year come out with a publication.

Maybe, maybe the editor-in-chief, uh, at the JBJS, who I know very well, might consider just publishing a, I don't know, a metric, an annual metric of the departments, uh, in North America.

Just, just a thought.

So the subscapularis was not really evident, and nobody knew about it.

And, um, anyway, I, I collected these cases, submitted these cases, and, uh, then, uh, the "American Journal of Bone and Joint Surgery" wrote back to me that this is probably a Swiss disease, that any- anyway, it does not occur in the United States.

No. [chuckles]

Then I had to take it back, and I brought it to the British Journal, and the British Journal then says, "Well, strange, but with the 16 cases photographed, it's difficult to say no." And so it became known as the subscapularis tear.

So first is Keba et al.

This is from July's JBJS.

And the senior author is Woody Sanka, who is a big guy in DDH right now.

Many papers coming from there from CHOP.